Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

156 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Predictive Value of Soluble PD-1, PD-L1, VEGFA, CD40 Ligand and CD44 for Nivolumab Therapy in Advanced Non-Small Cell Lung Cancer: A Case-Control Study.
Tiako Meyo M, Jouinot A, Giroux-Leprieur E, Fabre E, Wislez M, Alifano M, Leroy K, Boudou-Rouquette P, Tlemsani C, Khoudour N, Arrondeau J, Thomas-Schoemann A, Blons H, Mansuet-Lupo A, Damotte D, Vidal M, Goldwasser F, Alexandre J, Blanchet B. Tiako Meyo M, et al. Among authors: blanchet b. Cancers (Basel). 2020 Feb 18;12(2):473. doi: 10.3390/cancers12020473. Cancers (Basel). 2020. PMID: 32085544 Free PMC article.
Treatment of bevacizumab-induced hypertension by amlodipine.
Mir O, Coriat R, Ropert S, Cabanes L, Blanchet B, Camps S, Billemont B, Knebelmann B, Goldwasser F. Mir O, et al. Among authors: blanchet b. Invest New Drugs. 2012 Apr;30(2):702-7. doi: 10.1007/s10637-010-9549-5. Epub 2010 Sep 29. Invest New Drugs. 2012. PMID: 20878444
More on aprepitant for erlotinib-induced pruritus.
Mir O, Blanchet B, Goldwasser F. Mir O, et al. Among authors: blanchet b. N Engl J Med. 2011 Feb 3;364(5):487. doi: 10.1056/NEJMc1013027. N Engl J Med. 2011. PMID: 21288111 No abstract available.
Functional and clinical evidence of the influence of sorafenib binding to albumin on sorafenib disposition in adult cancer patients.
Tod M, Mir O, Bancelin N, Coriat R, Thomas-Schoemann A, Taieb F, Boudou-Rouquette P, Ropert S, Michels J, Abbas H, Durand JP, Dauphin A, Vidal M, Goldwasser F, Blanchet B. Tod M, et al. Among authors: blanchet b. Pharm Res. 2011 Dec;28(12):3199-207. doi: 10.1007/s11095-011-0499-1. Epub 2011 Jun 21. Pharm Res. 2011. PMID: 21691893
A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasma.
Faivre L, Gomo C, Mir O, Taieb F, Schoemann-Thomas A, Ropert S, Vidal M, Dusser D, Dauphin A, Goldwasser F, Blanchet B. Faivre L, et al. Among authors: blanchet b. J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Aug 1;879(23):2345-50. doi: 10.1016/j.jchromb.2011.06.026. Epub 2011 Jun 22. J Chromatogr B Analyt Technol Biomed Life Sci. 2011. PMID: 21737360
Drug-induced effects on erlotinib metabolism.
Mir O, Blanchet B, Goldwasser F. Mir O, et al. Among authors: blanchet b. N Engl J Med. 2011 Jul 28;365(4):379-80. doi: 10.1056/NEJMc1105083. N Engl J Med. 2011. PMID: 21793762 No abstract available.
Sorafenib exposure decreases over time in patients with hepatocellular carcinoma.
Arrondeau J, Mir O, Boudou-Rouquette P, Coriat R, Ropert S, Dumas G, Rodrigues MJ, Rousseau B, Blanchet B, Goldwasser F. Arrondeau J, et al. Among authors: blanchet b. Invest New Drugs. 2012 Oct;30(5):2046-9. doi: 10.1007/s10637-011-9764-8. Epub 2011 Oct 29. Invest New Drugs. 2012. PMID: 22038662
156 results